To further investigate the effect of DNASE1L3 on glycolysis pathways, we explored the relationship between serum DNASE1L3 activity and cancer glycometabolism reprogramming in patients with HCC. The gene discussed is DNASE1L3; the disease is hepatocellular carcinoma.